reviewJournal of the American College of CardiologyOct 1, 2023HYBRID OA

Tricuspid Valve Academic Research Consortium Definitions for Tricuspid Regurgitation and Trial Endpoints

Columbia University Irving Medical Center · Cardiovascular Research Foundation · +38 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

Interest in the pathophysiology, etiology, management, and outcomes of patients with tricuspid regurgitation (TR) has grown in the wake of multiple natural history studies showing progressively worse outcomes associated with increasing TR severity, even after adjusting for multiple comorbidities. Historically, isolated tricuspid valve surgery has been associated with high in-hospital mortality rates, leading to the development of transcatheter treatment options. The aim of this first Tricuspid Valve Academic Research Consortium document is to standardize definitions of disease etiology and severity, as well as endpoints for trials that aim to address the gaps in our knowledge related to identification and…

Citation impact

187
total citations
FWCI
39.65
Percentile
100%
References
116
Citations per year

Authors

55

Topics & keywords

Keywords
  • Medicine
  • Clinical endpoint
  • Etiology
  • Clinical trial
  • Tricuspid valve
  • Natural history
  • Regurgitation (circulation)
  • Internal medicine
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.